Durolane® Injection for Clinics

Durolane® is a sterile, non-animal hyaluronic acid gel supplied in a single-use prefilled syringe for intra-articular administration by trained clinicians. It supports osteoarthritis care pathways as a supplemental synovial lubricant and aids joint procedures in ambulatory settings. Your facility can source this line through US distribution to align schedules and maintain continuity.

This single-injection format streamlines appointment flow and reduces repeat visit burden for your team. Med Wholesale Supplies serves licensed clinics and healthcare professionals with authentic, brand-name medical products sourced through vetted distributors.

What Durolane Is and How It Works

This intra-articular preparation is a non-animal stabilized sodium hyaluronate (NASHA) formulation designed for joint spaces. As a viscoelastic supplement, it can support normal lubrication and shock-absorption functions within synovial cavities during standard care pathways. The gel’s cross-linked architecture helps maintain residence time compared with simple hyaluronate solutions, aiding procedural efficiency.

As a sodium hyaluronate injection in a viscoelastic gel, it is delivered directly into the joint space. The unit is single-use and sterile for one patient. The formulation is non-animal in origin and produced under rigorous quality controls. Clinicians typically integrate it with imaging-guided techniques when appropriate, based on institutional protocols and provider preference.

Hyaluronate is a naturally occurring glycosaminoglycan present in synovial fluid. In this class, the gel is intended to temporarily supplement the joint’s native viscoelastic environment. The intent is to support procedural comfort and joint mechanics while the patient proceeds through their broader osteoarthritis plan of care. Because this is an intra-articular product, clinicians confirm injection site, technique, and aseptic preparation per local policy. Post-injection observation protocols may be used at the clinic’s discretion.

Professional Applications

Orthopedic and rheumatology teams employ this class as a procedural adjunct within osteoarthritis service lines. Typical use includes a hyaluronic acid knee injection performed in clinic, with joint selection and technique determined by the provider. It may also be considered in other synovial joints where a viscosupplement approach fits the treatment plan.

For program design and patient-flow planning, many teams align this option with existing Orthopedic Injections and Rheumatology services. Cross-specialty operations that offer aesthetic hyaluronic acid procedures may also review RRS HA Long Lasting to streamline inventory handling, staff training, and supply integration across departments.

In orthopedic and sports-medicine settings, the clinic may integrate this syringe into ultrasound-guided procedures when localization is necessary. For knee-focused programs, the care team can consolidate education, consent, and injection in a single visit when appropriate, minimizing rebookings and supply pulls. Rheumatology services may include the gel in active osteoarthritis management alongside physical therapy, weight-management counseling, and other supportive modalities. Within procedural suites, consistent gel viscosity supports predictable hand feel during injection, which can aid standardization across multiple providers.

For background on category selection and clinical positioning, your team can reference evidence summaries such as HA Comparison and Gel Injections for Knees, as well as broader reviews like HA Options.

Key Features

• Single-use unit: sterile syringe intended for one patient and one joint.
• NASHA technology: non-animal stabilized hyaluronic acid with consistent rheology.
• Branded format: Durolane prefilled syringe ready for straightforward setup.
• Workflow fit: single-visit plan can reduce multi-appointment scheduling.
• Traceability: lot number and expiry are clearly visible on labeling.
• Quality focus: manufactured to high standards for device cleanliness and purity.
• Expected local reactions: redness, itching, swelling, or bruising at the injection site.
• Documentation: English-language carton and instructions support staff training.
• Ergonomic handling: smooth plunger action supports controlled gel expression.
• Sealed integrity: tamper-evident closure helps maintain sterility to point of use.

Benefits in Practice

As a single-use hyaluronate supplied in a sterile syringe, this product can simplify appointment logistics and reduce inventory complexity for clinics that prefer single-visit pathways. Many clinics select the Durolane single injection approach to simplify recall intervals.

Standardized viscosity and packaging support predictable handling for injector-needle preparation and instrument setup. The single-patient configuration also helps reduce cross-contamination risk and simplifies post-procedure documentation, device reconciliation, and charge capture within electronic systems. Unit-of-use packaging makes purchasing straightforward for inventory teams. It simplifies lot tracking, reduces partial-use waste, and supports charge capture accuracy. Standardized supply also eases cross-coverage among providers, enabling consistent setup regardless of site location.

Composition & Ingredients

The sodium hyaluronate Durolane platform is based on non-animal stabilized hyaluronic acid (NASHA). This class is designed as a viscoelastic gel for intra-articular administration. The vehicle is sterile and intended solely for intra-articular use.

• Active: Non-animal stabilized hyaluronic acid (NASHA).
• Class: Sterile viscoelastic hyaluronate gel.
• Intended route: intra-articular administration only.

NASHA is formulated to maintain a stable, purified hyaluronate network with defined physical characteristics. The absence of animal-derived components can be helpful for patients with specific sensitivities; evaluate per your facility’s screening process. Review the full package insert for complete ingredient details and any excipients. Do not mix with other intra-articular solutions unless directed by the labeling or institutional policy.

Packaging & Supply

This item is supplied as a single-use, sterile Durolane 3 mL syringe in an English-labeled carton. Each unit is sealed and intended for one patient only. The outer packaging typically includes instructions for use and a needle as provided by the manufacturer.

Units are designed for immediate setup in procedural rooms, with clear visibility of lot and expiry on the label to aid documentation and traceability. Discard any unused portion after administration. Store and handle according to the manufacturer’s recommendations on the carton and insert; do not freeze.

The compact carton fits common medication bins and procedure carts, easing storage in ambulatory rooms. Barcoding on the unit enables scanning into inventory or EMR systems that support device tracking. Dispose of sharps using standard protocols after use.

Ordering & Logistics

Licensed account verification is required before purchase. Sign in to view tiered pricing and eligibility for volume or contract terms aligned to your practice size and frequency of use. Our team can coordinate fulfillment windows to match clinic schedules and support predictable room utilization.

For planning, typical lead times are communicated at checkout. Larger orders may be staged to align with clinic calendars and site delivery hours. Our logistics team can coordinate shipments to avoid weekend arrivals where possible, helping protect chain-of-custody and onsite staffing needs. Facilities that operate formulary review committees can request documentation to support product evaluation and onboarding. We can also list the item on purchase agreements with defined minimums to stabilize supply and simplify budgeting.

Comparable Products

Clinics evaluating viscosupplements often compare syringe volumes, cross-linking methods, and visit counts across brands. Explore our Orthopedic Injections category to review alternatives with different dosing schedules or packaging profiles. For high-level comparisons, see HA Comparison and HA Options.

Selection often centers on visit count, syringe volume, and polymer technology. Some alternatives use non-crosslinked hyaluronate with multi-visit schedules, while others, like single-visit formats, aim to reduce clinic touchpoints. Use internal policies and payer guidance when confirming substitutions.

Pricing & Access

Sign in to your verified account to view current pricing. Volume tiers and contract pricing are available for eligible clinics, ambulatory centers, and integrated networks. For formulary planning, request a quote with projected monthly usage to evaluate cost-per-procedure under your purchasing model.

Availability & Substitutions

Supply levels can vary by week based on manufacturer allocations and regional demand. If a substitution is required, confirm with your clinical lead to ensure the alternative matches the intended joint, volume, and visit plan. See the Brand Overview page for line-specific details during transition planning.

When evaluating alternatives, confirm the labeled route, joint indications, and language of packaging to maintain consistency across sites. Ensure staff education materials reflect the specific product in stock during the transition period.

Authoritative Sources

• DUROLANE Manufacturer Information
• MedlinePlus: Hyaluronic Acid, Intra-articular
• NIAMS: Osteoarthritis Overview

Ready to add to your clinic formulary? Sign in to order with temperature-controlled handling when required and tracked US delivery.